P1367: REFINED PHENOTYPE OF SENESCENT T CELLS UNVEILS HIGH ANTI-TUMOR ACTIVITY DESPITE IMPAIRED PROLIFERATION AND DISTURBED METABOLIC ACTIVITY: NEW IMPLICATIONS FOR CANCER IMMUNOTHERAPY

• Kevin Legscha,
• Abdulkadir Yilmaz,
• Lea Märker,
• Edite Antunes,
• Catherine Wölfel,
• Borhane Guezguez,
• Stefan Porubsky,
• Matthias Theobald,
• Hakim Echchannaoui

Affiliations

Kevin Legscha

1 University Medical Center Mainz, III. Medical Department, Hematology and Oncology, Mainz, Germany

Abdulkadir Yilmaz

1 University Medical Center Mainz, III. Medical Department, Hematology and Oncology, Mainz, Germany

Lea Märker

1 University Medical Center Mainz, III. Medical Department, Hematology and Oncology, Mainz, Germany

Edite Antunes

1 University Medical Center Mainz, III. Medical Department, Hematology and Oncology, Mainz, Germany

Catherine Wölfel

1 University Medical Center Mainz, III. Medical Department, Hematology and Oncology, Mainz, Germany

Borhane Guezguez

1 University Medical Center Mainz, III. Medical Department, Hematology and Oncology, Mainz, Germany

Stefan Porubsky

3 University Medical Center Mainz, Intitute of Pathology, Mainz, Germany

Matthias Theobald

1 University Medical Center Mainz, III. Medical Department, Hematology and Oncology, Mainz, Germany

Hakim Echchannaoui

1 University Medical Center Mainz, III. Medical Department, Hematology and Oncology, Mainz, Germany